Second Allogeneic Transplantation for Relapsed Acute Leukemia after Initial...
AbstractWe retrospectively reviewed the medical records of 45 patients with relapsed acute leukemia after initial allogeneic hematopoietic stem ell transplantation (allo-HSCT). Among 45 patients, a...
View ArticleClinical Outcome of Hematopoietic Stem Cell Transplantation for Philadelphia...
AbstractTo identify factors affecting transplant outcome, data from 65 Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph + ALL) patients who had undergone allogeneic hematopoietic...
View ArticleEfficacy and tolerability of Entecavir for hepatitis B virus infection after...
AbstractIntroductionHepatitis B virus (HBV) flare is a serious problem following hematopoietic stem cell transplantation (HSCT), and the mortality rate is high if severe hepatitis occurs.Case...
View ArticleThe Predictive Value for Pulmonary Infection by Area Over the Neutrophil...
AbstractWe evaluated the predictive value of the D-index for pulmonary infection in the early phase of reduced intensity stem cell transplantation (RIST). Out of 68 patients, ten patients developed a...
View ArticleImpact of prior azacitidine on the outcome of allogeneic hematopoietic...
AbstractTo clarify the clinical impact of prior use of azacitidine (AZA) on outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for myelodysplastic syndrome (MDS), we...
View ArticleClinical impact of hematogones on outcomes of allogeneic hematopoietic stem...
AbstractIncreased levels of normal B cell precursors, termed hematogones (HGs), are observed in regenerating bone marrow after chemotherapy or hematopoietic stem cell transplantation (HSCT). Recent...
View ArticleClinical utility of high-flow nasal cannula oxygen therapy for acute...
AbstractA high-flow nasal cannula (HFNC) is a newly developed device that enables high-flow oxygen therapy for patients with serious cardiopulmonary problems, but there are few data regarding its use...
View ArticleThe clinical features of fatal cyclophosphamide-induced cardiotoxicity in a...
AbstractCyclophosphamide (CY) cardiotoxicity induces a rare lethal complication associated with its use. The minimum dose for cardiac toxicity is still not known, although there are no reports of CY...
View ArticleComparison of transplant outcomes and economic costs between biosimilar and...
AbstractFrom January 2012 to September 2015, 49 patients received biosimilar filgrastim (BF) after allogeneic bone marrow transplantation (BMT, n = 31) or peripheral stem cell transplantation (PBSCT, n...
View ArticleCentral Nervous System Involvement at the Time of Allogeneic Hematopoietic...
AbstractRecent reports suggested that central nervous system (CNS) involvement (CNS+) in patients with acute myeloid leukemia (AML) before allogeneic hematopoietic stem cell transplantation (allo-HSCT)...
View ArticleClinical impact of pre-transplant gut microbial diversity on outcomes of...
AbstractPost-transplant microbial diversity in the gastrointestinal tract is closely associated with clinical outcomes following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However,...
View ArticlePredictive implications of albumin and C-reactive protein for progression to...
AbstractBackgroundStenotrophomonas maltophilia (S. maltophilia) bacteremia causes significant morbidity and mortality in immunocompromised hosts. However, incidence and risk factors for mortality in S....
View ArticleSuccessful hematopoietic stem-cell mobilization with plerixafor plus...
AbstractAutologous stem-cell transplantation is an effective procedure for the treatment of multiple myeloma, and involves the collection of hematopoietic stem cells (HSCs). However, in some patients,...
View ArticleSignificance of FLT3 -tyrosine kinase domain mutation as a prognostic factor...
AbstractThe prognostic significance of FLT3-tyrosine kinase domain (TKD) mutations remains unknown. To investigate the prognostic impact of FLT3-TKD, 676 de novo acute myeloid leukemia (AML), we...
View ArticleUnmanipulated haploidentical hematopoietic stem cell transplantation using...
AbstractAllogeneic hematopoietic stem cell transplantation (HSCT) could be the only curative therapy for patients with relapsed/refractory acute leukemia (RRAL). Many reports have described...
View ArticleGeriatric nutritional risk index as a useful prognostic factor in second...
AbstractSecond allogeneic hematopoietic stem cell transplantation (allo-HSCT) has a low survival outcome and a high non-relapse mortality (NRM) rate which is a major obstacle to this treatment. We...
View ArticleBone turnover markers as an aid to monitor osteoporosis following allogeneic...
AbstractBone turnover markers (BTMs) are useful parameters for assessing fracture risk and unlike bone mineral density (BMD), can be measured at any institution. However, BTM values have not been...
View Article
